5 Questions for . . . Ousseny Zerbo
Division of Research investigator Ousseny Zerbo, PhD, describes his long journey from his childhood and education in Burkina Faso to becoming an epidemiologist in Northern California.
Head and neck cancer patients benefit from patient-reported outcome surveys
Kaiser Permanente study shows survey tools routinely used in clinical trials can be successfully integrated into electronic medical records.
Predictive model paired with case management reduced rate of readmitted hospital patients
A follow-up program for Kaiser Permanente Northern California patients discharged from the hospital was associated with reduced readmissions without increased mortality, new research in the journal BMJ suggests.
For stomach cancer patients, a regionalized cancer care program can improve survival
New study describes how patients and physicians benefitted when Kaiser Permanente Northern California established a virtual, multidisciplinary gastric cancer team.
New tool for early identification of COVID-19 surges
Health systems could use data from routine clinical care to identify the onset of upcoming COVID-19 surges as many as 6 weeks before they occur, Kaiser Permanente researchers found in a study published in the journal BMJ Open.
Migraine genetics study finds intriguing connections with other medical conditions
A Kaiser Permanente genetic analysis found 82 locations on the human genome associated with migraine, 48 of them newly identified, including 3 specific to women, who experience migraine much more frequently than men.
Risk of blood clots more than 3-fold higher in hospitalized adults with COVID-19
Kaiser Permanente study found Black patients as well as patients who had obesity, liver disease, or sepsis or other signs of infection were among those more likely to be at high risk for a blood clot.
‘COVID toes’ were likely not caused by COVID-19, in most cases
Kaiser Permanente study suggests the increased incidence of chilblains — or, COVID toes — seen during pandemic was related to behavior changes, not the coronavirus.
Kaiser Permanente researchers and physicians take part in leading clinical oncology conference
Research presented at the American Society for Clinical Oncology annual meeting amplified the ways the Division of Research and The Permanente Medical Group advance cancer care.
Uncommon kidney disorder significantly increases risk of heart disease and end-stage kidney disease
Kaiser Permanente study findings highlight the need for patients with primary nephrotic syndrome to be identified as early as possible to prevent complications.
